Epithelix
PrivateLast Round
Grant
Dec 1, 2020
Total Funding Raised
$146,100
Company Overview
Epithelix operates in Healthcare & Life Sciences and is based in Plan-les-Ouates. Its latest recorded funding round was a Grant round in December 2020.
Epithelix is a biotechnology company that provides alternative in-vitro solutions to animal experimentation for evaluating the effects of drugs and the toxicity of chemical compounds on the human respiratory tract.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epithelix Comparables
Compare Epithelix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlveoliX AG | 86% | |
| ImmuONE | 84% | |
| Sartorius Aktiengesellschaft | 79% |
For institutional investors. Book with your work email.
Epithelix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2020 | ||||
| Grant | Jun 18, 2008 | ||||
| Grant | Jun 18, 2007 | ||||
| Seed | Mar 1, 2006 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epithelix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| W.A. de Vigier Foundation | Grant |
| Unitec | Seed |
| Fondation Dr. René Liechti | Grant |
| Foundation Eclosion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 40% MoM, reaching 1.6K.
- Apr 15, 2026
Monthly visitors increased 2440% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 9, 2026
Epithelix attends the LIVe event and jointly awards free tissue models in 2026
For institutional investors. Book with your work email.
Epithelix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epithelix's valuation, stock price, and market status.
Is Epithelix a public or private company?
Epithelix is a private company.
What is the current stock price of Epithelix?
Epithelix is a private company, so its shares have no public market price. Caplight tracks Epithelix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epithelix worth (valuation)?
Valuation information for Epithelix is not publicly available.
Can I buy Epithelix stock?
Epithelix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epithelix's last funding round?
Epithelix's most recent funding round was Grant on December 1, 2020.
Who are the main investors in Epithelix?
Key investors in Epithelix include Foundation Eclosion.
Will Epithelix IPO soon?
No public IPO plans have been announced for Epithelix.
How can I track Epithelix secondary market activity?
Caplight tracks bids, offers, and trades in Epithelix's shares on secondary markets.